Voyager Therapeutics, Inc. (VYGR) Net margin 2016–2025
Voyager Therapeutics, Inc. (VYGR) net profit margin by fiscal year — reported net income divided by reported revenue.
-296.5%FY2025 · since FY2016: -282.7% → -296.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -296.5% | -215.3 pp |
| FY2024 | -81.3% | -134.2 pp |
| FY2023 | 52.9% | +166.4 pp |
| FY2022 | -113.4% | +76.8 pp |
| FY2021 | -190.3% | -211.8 pp |
| FY2020 | 21.5% | +63.2 pp |
| FY2019 | -41.8% | +1117.0 pp |
| FY2018 | -1158.8% | -461.2 pp |
| FY2017 | -697.6% | -414.9 pp |
| FY2016 | -282.7% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice